ArticleACS omega2024
Poly(2-alkyl/aryl-2-oxazoline)-Imidazole Complexes as Thermal Latent Curing Agents for Epoxy Resins.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One-component epoxy resins (OCERs) with improved stability (shelf life) and controlled curing temperatures were prepared using epoxy resins and polyoxazoline-imidazole (POZ-Im) based thermal latent curing agents (TLCs). POZ homopolymers with molar masses of 1000, 2000, and 5000 g/mol were obtained via cationic ring-opening polymerization (CROP) of 2-ethyl-2-oxazoline, 2-propyl-2-oxazoline, 2-pentyl-2-oxazoline, and 2-phenyl-2-oxazoline. TLCs were prepared by physically entrapping imidazole, the curing agent, in the POZ matrix at the homopolymer/Im (HP/Im) ratios of 1:1 and 5:1 and characterized by FTIR and TGA. TLCs were then mixed with bisphenol A diglycidyl ether (DGEBA) to obtain OCERs with Im concentrations of 1, 3, and 5 wt %. Dynamic DSC tests were performed to determine the effect of the pendant group and molar mass of POZ, the POZ/Im ratio, and Im concentration on the curing behavior of the OCERs, whereas isothermal DSC tests were carried out to examine their thermal stability and optimal curing temperatures. Optical microscopy was performed to study the compatibility of the TLCs with DGEBA. This study showed that the dispersion quality of TLCs is highly associated with the compatibility of POZs and DGEBA, which affected the release of Im, thus left limit temperatures of curing. In addition, higher left limit temperatures were obtained when the POZ/Im ratio increased. Isothermal DSC results conformed to the improved stability and better thermal latency of the samples with a POZ/Im ratio of 5:1. Moreover, the higher left limit temperatures were obtained with the lowest molar mass of POZ due to the better interaction between the -OH end group of POZ and Im. The shelf life of PEOZ 1K-Im 5:1 1% OCER was predicted at -20, 0, and 20 °C, with an estimated 15.3 days at 20 °C using isothermal DSC and rheology at 50, 60, and 70 °C. Overall, this research contributes to the development of OCERs by introducing POZ-Im complexes as novel TLCs. The findings shed light on the importance of compatibility in achieving optimal dispersion and release of Im and the role of the POZ/Im ratio and POZ molar mass in controlling left limit temperatures, ultimately influencing the curing behavior of OCERs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.